← back to search

James B. Meigs

Harvard University · US
Area of research
Genetics · Endocrinology, Diabetes and Metabolism
Research interest
is the cause and prevention of type 2 diabetes and cardiovascular disease using biochemical and genetic epidemiology and health services translational research approaches. In 2009 he was awarded the ADA’s prestigious Kelly West Award for Outstanding Achievement in Diabetes Epidemiology. He is a senior leader of many major large international T2D genomics consortia, including MAGIC, DIAGRAM, AAGILE, CHARGE- and TOPMed-diabetes, NIDDK T2D AMP/CMD and the VA’s MVP cardiometabolic work group, and is the PI, co-PI or co-investigator on many NIH grants, currently including UM1 DK078616-13 TOPMed Omics of T2D and Quantitative traits and R01 HL151855-01 TOPMed Omics of CVD in T2D and Quantitative traits. He has formally mentored over 50 early career investigators, most of whom have remained in aca
h-index
168
citations
136,420
works
834
NIH funding
primary concept
Medicine
email

Recent publications

Heterogeneous effects of genetic variants and traits associated with fasting insulin on cardiometabolic outcomes
Nature Communications 2025cited by 11position: middledoi
Polygenic risk score for type 2 diabetes shows context-dependent effects across populations
Nature Communications 2025cited by 4position: middledoi
Genome-Wide Association Study of Hypoglycemia in Adults With Diabetes in the Million Veteran Program.
2025cited by 0position: contributordoi
Common genetic variants near <i>SLC2A2</i> and glycemic response to glimepiride in the GRADE comparative effectiveness clinical trial
2025cited by 0position: contributordoi
Selection, optimization and validation of ten chronic disease polygenic risk scores for clinical implementation in diverse US populations
Nature Medicine 2024cited by 182position: middledoi
Cardiovascular Risk Estimation Is Suboptimal in People With HIV
Journal of the American Heart Association 2024cited by 29position: middledoi
Adaptive selection at G6PD and disparities in diabetes complications
Nature Medicine 2024cited by 28position: middledoi
Cardiovascular Risk Estimation Is Suboptimal in People With HIV.
2024cited by 22position: contributordoi
Polygenic Risk for Type 2 Diabetes in African Americans
Diabetes 2024cited by 8position: middledoi
Development of electronic health record based algorithms to identify individuals with diabetic retinopathy
Journal of the American Medical Informatics Association 2024cited by 6position: middledoi
Time-to-Event Genome-Wide Association Study for Incident Cardiovascular Disease in People With Type 2 Diabetes.
2024cited by 4position: contributordoi
A Large-Scale Genome-Wide Gene-Sleep Interaction Study in 732,564 Participants Identifies Lipid Loci Explaining Sleep-Associated Lipid Disturbances
medRxiv 2024cited by 1position: middledoi
GWAS of random glucose in 476,326 individuals provide insights into diabetes pathophysiology, complications and treatment stratification
Nature Genetics 2023cited by 100position: middledoi
GWAS of random glucose in 476,326 individuals provide insights into diabetes pathophysiology, complications and treatment stratification
Nature Genetics 2023cited by 92position: contributordoi
Genome-wide association study and functional characterization identifies candidate genes for insulin-stimulated glucose uptake
Nature Genetics 2023cited by 74position: middledoi
Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Incident Type 2 Diabetes Risk
Diabetes Care 2023cited by 63position: middledoi
Loci for insulin processing and secretion provide insight into type 2 diabetes risk
The American Journal of Human Genetics 2023cited by 44position: middledoi
Multi-tissue epigenetic analysis identifies distinct associations underlying insulin resistance and Alzheimer’s disease at CPT1A locus
Clinical Epigenetics 2023cited by 19position: middledoi
The power of TOPMed imputation for the discovery of Latino-enriched rare variants associated with type 2 diabetes
Diabetologia 2023cited by 17position: middledoi
Investigating Gene–Diet Interactions Impacting the Association Between Macronutrient Intake and Glycemic Traits
Diabetes 2023cited by 14position: middledoi
Type 2 Diabetes Modifies the Association of CAD Genomic Risk Variants With Subclinical Atherosclerosis
Circulation Genomic and Precision Medicine 2023cited by 9position: middledoi
Systematic review of precision subclassification of type 2 diabetes
2023cited by 7position: contributordoi
Genetic Effect on Body Mass Index and Cardiovascular Disease Across Generations
Circulation: Genomic and Precision Medicine 2023cited by 5position: contributordoi
Time-to-Event Genome-Wide Association Study for Incident Cardiovascular Disease in People with Type 2 Diabetes Mellitus
2023cited by 1position: contributordoi
Polygenic Scores for Longitudinal Prediction of Incident Type 2 Diabetes in an Ancestrally and Medically Diverse Primary Care Network
2023cited by 0position: contributordoi
A multiancestry genome-wide association study of unexplained chronic ALT elevation as a proxy for nonalcoholic fatty liver disease with histological and radiological validation
Nature Genetics 2022cited by 188position: middledoi
Development and validation of a trans-ancestry polygenic risk score for type 2 diabetes in diverse populations
Genome Medicine 2022cited by 168position: middledoi
Genome-wide polygenic score to predict chronic kidney disease across ancestries
Nature Medicine 2022cited by 160position: middledoi
A framework for detecting noncoding rare-variant associations of large-scale whole-genome sequencing studies
Nature Methods 2022cited by 109position: middledoi
Patient and provider perspectives on polygenic risk scores: implications for clinical reporting and utilization
Genome Medicine 2022cited by 90position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 13 papers (2019–2025)Josée Dupuis · Boston University10 papers (2012–2023)José C. Florez · Broad Institute6 papers (2012–2023)Caroline S. Fox · Tallaght University Hospital6 papers (2012–2014)Jose C. Florez · University of Tartu6 papers (2019–2024)Ramachandran S. Vasan · Department of Public Health6 papers (2012–2023)Joseph M. Massaro · Boston University5 papers (2012–2024)Ralph B. D’Agostino · Atrium Health Wake Forest Baptist5 papers (2012–2024) · 5 papers (2012–2018)Steven Grinspoon · Harvard University4 papers (2012–2024)Daniel Levy · Icahn School of Medicine at Mount Sinai4 papers (2016–2023)Deborah J. Wexler · Harvard University4 papers (2014–2021)Ching‐Ti Liu · Boston University4 papers (2018–2023)Josep M. Mercader · University of Pennsylvania4 papers (2021–2024)Ching-Ti Liu · University of Edinburgh4 papers (2019–2024)Aaron Leong · Children's Hospital of Pittsburgh4 papers (2019–2023)Virginia A. Triant · Harvard University4 papers (2012–2024)David S. Siscovick · New York Academy of Medicine4 papers (2012–2020)Jerome I. Rotter · IST Research3 papers (2012–2022) · 3 papers (2020–2021)